Evercore ISI Group Initiates Coverage On Icosavax with Outperform Rating, Announces Price Target of $50
Evercore ISI Group analyst Josh Schimmer initiates coverage on Icosavax (NASDAQ:ICVX) with a Outperform rating and announces Price Target of $50.